Polymyalgia rheumatica is an inflammatory disorder that causes muscle pain and stiffness in various parts of the body. It most commonly affects the: shoulders neck arms hips The symptoms often appear ...

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread pain, stiffness, or aching in the large muscle groups, especially around the shoulders, hips, lower back, neck, and ...

This week we are going to continue in our series of rheumatologic conditions to discuss the autoimmune condition called “PMR” or polymyalgia rheumatica. Polymyalgia rheumatica is a syndrome of pain ...

The US Food and Drug Administration (FDA) approved sarilumab (Kevzara) today for the treatment of polymyalgia rheumatica (PMR) in adults who have had an inadequate response to corticosteroids or could ...

The exact cause of polymyalgia rheumatica (PMR) is unknown. Studies of patients with PMR and giant-cell arteritis indicate that PMR could be a vasculitis limited to the subclavian or axillary arteries ...

Polymyalgia rheumatica and giant-cell arteritis are closely related conditions that affect persons of middle age and older and frequently occur together. Many authorities consider them to be different ...

Polymyalgia rheumatica (PMR) can make everyday activities such as household chores, bathing, or going up the stairs feel difficult. The inflammatory condition is known for symptoms like muscle pain, ...

Polymyalgia rheumatica is widely acknowledged as the most common form of inflammatory rheumatic disease in the elderly. Two recent studies by Hernandez-Rodriguez et al. and Dasgupta et al. attempt to ...

Please provide your email address to receive an email when new articles are posted on . Patients were more likely to achieve sustained remission with sarilumab vs. placebo. The most common adverse ...

Patients with polymyalgia rheumatica (PMR) are at 2.5 times the risk for a vascular event than matched control patients, with the greatest risk occurring in patients younger than 60 years, according ...

Tofacitinib (Xeljanz) appeared highly effective against polymyalgia rheumatica (PMR) in a small single-arm trial, researchers said, suggesting another potential alternative to long-term ...

Polymyalgia rheumatica is an inflammatory condition that affects persons older than 50 years of age and is characterized by pain in both shoulders with or without hip or neck pain (or both) and with ...